5637 cells (CLS Cell Lines Service GmbH)
Structured Review
5637 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5637+cells/5637+Cells/custom%40300105%4042054808
Average 93 stars, based on 13 article reviews
Images
Related Articles
Knockdown:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and Infection:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and Transfection:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and Cell Culture:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and Imaging:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and Construct:Article Title: Oxymatrine Inhibits PKM2-Mediated Glycolysis and Enhances Cisplatin Sensitivity in Bladder Cancer Article Snippet: 000 (Invitrogen, USA). Forty-eight hours later, cells were collected for further use. Cell treatment HT-1376 and |
